Yalçın K - Search Results

1

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.

Keskin O, Wedemeyer H, Tüzün A, Zachou K, Deda X, Dalekos GN, Heidrich B, Pehlivan S, Zeuzem S, Yalçın K, Gürel S, Tabak F, Idilman R, Bozkaya H, Manns M, Yurdaydin C. Keskin O, et al. Among authors: yalcin k. Clin Gastroenterol Hepatol. 2015 Dec;13(13):2342-49.e1-2. doi: 10.1016/j.cgh.2015.05.029. Epub 2015 Jun 1. Clin Gastroenterol Hepatol. 2015. PMID: 26044319 Clinical Trial.

2

Famciclovir treatment of chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Yurdaydin C, et al. Among authors: yalcin k. J Hepatol. 2002 Aug;37(2):266-71. doi: 10.1016/s0168-8278(02)00162-9. J Hepatol. 2002. PMID: 12127433 Clinical Trial.

3

Markers of disease activity in chronic hepatitis B virus infection.

Yalcin K, Degertekin H, Yildiz F, Celik Y. Yalcin K, et al. Clin Invest Med. 2003 Feb;26(1):27-34. Clin Invest Med. 2003. PMID: 12659467

4

Comparison of 12-month courses of interferon-alpha-2b-lamivudine combination therapy and interferon-alpha-2b monotherapy among patients with untreated chronic hepatitis B.

Yalcin K, Degertekin H, Yildiz F, Celik Y. Yalcin K, et al. Clin Infect Dis. 2003 Jun 15;36(12):1516-22. doi: 10.1086/375085. Epub 2003 Jun 6. Clin Infect Dis. 2003. PMID: 12802750 Clinical Trial.

5

The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy.

Yalcin K, Degertekin H, Yurdaydin C, Bozdayi M, Bozkaya H. Yalcin K, et al. Eur J Gastroenterol Hepatol. 2003 Jul;15(7):819-23. doi: 10.1097/01.meg.0000059154.68845.d4. Eur J Gastroenterol Hepatol. 2003. PMID: 12811314

6

A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.

Yalcin K, Degertekin H, Yildiz F, Kilinc N. Yalcin K, et al. J Gastroenterol. 2003;38(8):796-800. doi: 10.1007/s00535-002-1149-5. J Gastroenterol. 2003. PMID: 14505137

7

The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.

Yalcin K, Danis R, Degertekin H, Alp MN, Tekes S, Budak T. Yalcin K, et al. J Clin Gastroenterol. 2003 Oct;37(4):330-5. doi: 10.1097/00004836-200310000-00012. J Clin Gastroenterol. 2003. PMID: 14506391 Clinical Trial.

8

Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.

Yalçin K, Değertekin H, Alp MN, Tekeş S, Satici O, Budak T. Yalçin K, et al. Turk J Gastroenterol. 2003 Sep;14(3):157-63. Turk J Gastroenterol. 2003. PMID: 14655057 Free article.

9

Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.

Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S. Yalcin K, et al. Infection. 2004 Feb;32(1):24-9. doi: 10.1007/s15010-004-3010-7. Infection. 2004. PMID: 15007739

10

A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.

Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C. Yalçin K, et al. Turk J Gastroenterol. 2004 Mar;15(1):14-20. Turk J Gastroenterol. 2004. PMID: 15264116 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page